• support@madhedgefundtrader.com
  • Member Login
Mad Hedge Fund Trader
  • Home
  • About
  • Store
  • Luncheons
  • Testimonials
  • Contact Us
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu

Tag Archive for: (AMZN)

Mad Hedge Fund Trader

The Market Outlook for the Week Ahead, or Welcome to WWIII

Diary, Newsletter

The market finally found something worse than inflation to rattle it: WWIII.

I’m not expecting my call-up papers from the Marine Corps anytime soon. After all, there isn’t a war that is about to happen. In any case, if the defense of the nation relies upon me as a pilot, we are in big trouble.

The market clearly thought otherwise last week, when the Dow swooned 1,200 points in two days. The Friday close was a dog’s breakfast.

It gets worse.

The collapse sets up a perfect “head and shoulders” top which the hedge fund community has been gunning for all year. That beckons eventual lows that will finally bring us into decent LEAPS territory, especially if the Volatility Index (VIX) leaps over $40.

Biden actually has a pretty good strategy going in the Ukraine. By announcing the time and date of the Russian invasion in advance, he boxes Putin into a corner, forcing him to put up or shut up.

It's really all one big chess game, with the two countries attempting to each gain maximum security advantages at minimum cost. Putin would love the Ukraine if he could get it. So did Hitler, Napoleon, and Genghis Khan before him.

Biden hopes to make the price so high it’s not worth it. After all, Hitler, Napoleon, and Genghis Khan didn’t come to good endings.

It’s really meaningless to fight this battle when modern national borders are rapidly dissolving anyway. Modern borders are increasingly being drawn by operating systems, apps, and security suites rather than lines on a map.

Of course, bonds were discounting a completely different scenario, that of peace, prosperity, and booming economies that demand more capital at higher interest rates. Fed members are now playing a game of competitive hawkishness, talking interest rates up and bond prices down.

It all sounds like a great short bond environment to me, which is why I have been running a triple short position since the beginning of the year. The best is yet to come.

So we flipped from being long everything in 2021 to short the works in 2022. That’s just the way markets work now. So, if you can’t stand the heat, get out of the kitchen.

Fed Now Pushing a Half-Point Hike, tanking the markets, and could deliver 100 basis points by July. Competitive hawkishness has broken out at the Fed. Looks like a bond short will be the trade of the year. Who knew? (You did).

Core CPI Comes in Hot at 7.5%, the highest since 1982, and hotter than expected. The news finally took bond prices to new multi-year lows and ten-year yields to 2.0%. One-third of this number is rent, which is rising at a record rate. Wages are up an eye-popping 5% YOY. Used car prices were up massively. Stocks took it on the news. It’s going to get worse before it gets better. The chances of a 50-basis point hike in March.

Real Yields Turn Positive, for the first time in a decade, at least for 30-year US treasury bonds. That is the real inflation-adjusted yield for TIPS, or Treasury Inflation-Protected Securities, which now yield 0.08%. Expect real yields to soar from here. Yes, positive returns for bonds at last!

JGB Yields Approach Five Year High, at 0.25%, so will the Bank of Japan be forced to raise rates for the first time in 21 years to come in line with the market. Quantitative Easing is also ending. Gee, do you think zero rates have worked? It's all part of an accelerating trend for more expensive global money.

Pfizer Hauls in $32 Billion From Covid, and another $22 billion for its antiviral Paxlovid. Still, the stock market is a “What have you done for me lately,” and the shares are off 20% since December.

NVIDIA Cancels ARM Purchase, ending its $66 billion attempt to buy market share. UK regulatory opposition was the issue. Buy (NVDA) on dips. The best-run company in the market has just suffered a 40% selloff.

GM to Ramp Up EV Production Sixfold This Year. Electric Escalade SUVs and trucks are the top priority. But while saying is one thing, doing is another. No mention has been made of how they will obtain the extra chips and batteries. Avoid (GM) a never-ending font of disappointment.

Weekly Jobless Claims
Prints at 223,000, well above the post-pandemic low of 188,000 in December. Continuing Claims post at 1,621,000.

Foreclosures are Soaring now that the pandemic relief is over. They were up 29% in January, double YOY levels. Florida leads in this troubled category. The numbers would be higher save for enormous rises in home prices which permit cash out refis.

My Ten-Year View

When we come out the other side of pandemic, we will be perfectly poised to launch into my new American Golden Age, or the next Roaring Twenties. With interest rates still at zero, oil cheap, there will be no reason not to. The Dow Average will rise by 800% to 240,000 or more in the coming decade. The American coming out the other side of the pandemic will be far more efficient and profitable than the old. Dow 240,000 here we come!

With near record volatility fading fast, my February month to date performance rocketed to a blistering 8.71% in only nine days. My 2022 year-to-date performance has exploded to an unbelievable 23.30%. The Dow Average is down -4.3% so far in 2022. It is the great outperformance on an index since Mad Hedge Fund Trader started 14 years ago.

With 30 trade alerts issued so far in 2022, there was too much going on to describe here. Check your inboxes.

That brings my 13-year total return to 535.86%, some 2.00 times the S&P 500 (SPX) over the same period. My average annualized return has ratcheted up to 44.04% for the first time. How long it will keep rising I have no idea, but as long as it is, I’m not complaining. When you’re hot, you have to be maximum aggressive.

We need to keep an eye on the number of US Coronavirus cases at 78 million and rising quickly and deaths topping 919,000, which you can find here.

On Monday, February 14 at 8:00 AM EST, US Consumer Inflation Expectations are out.

On Tuesday, February 15 at 8:30 AM, the New York Empire State Manufacturing Index is printed.

On Wednesday, February 16 at 8:30 AM, US Retail Sales for January are announced.

On Thursday, February 17 at 8:30 AM, Weekly Jobless Claims are published. Housing Starts and Building Permits for January are announced.

On Friday, February 18 at 7:00 AM, Existing Home Sales for January are disclosed. At 2:00 PM, the Baker Hughes Oil Rig Count are out.
 
As for me, I made the most unlikely of entries into journalism 50 years ago, thanks to basketball, Mensa, and the kindness of complete strangers.

Struggling as a part-time English teacher in Tokyo for Toyota, Sony, and Meiji Shipping, I noticed one day in the Japan Times an ad for a Mensa meeting, the organization for geniuses.

I joined and, after a few meetings, was invited to give a presentation on the subject of my choice at the next meeting. Since I had just obtained a degree in Biochemistry from UCLA, I spoke on the effects of THC (tetra hydro cannabinol) on the human brain. The meeting was exceptionally well attended by detectives from the Tokyo Police Department, as THC was then highly illegal.

At the end of the meeting, famed Australian journalist Murray Sayle approached me and said he could get me into the Foreign Correspondents Club of Japan. The big attraction was access to the Club’s substantial English language library.

Except for a few well-worn Playboy magazines coming out of the local US Air Force bases, there were almost no English language publications in Japan in those days.

So I joined as a corporate member at 22, the youngest of the 2,000-man club, eating lunch daily with the foreign correspondents on the 20th floor of the Yurakcho Denki Building in central Tokyo. It was just across the street from General Douglas MacArthur’s WWII occupation headquarters.

Many correspondents were holdovers from WWII and had fought their way to Japan on the long island-hopping campaign. Once in Tokyo, they never left, were treated like visiting royalty, paid well, and besieged by beautiful women.

At 6’4” it was only weeks before I was recruited for the club’s basketball team. We played the team from the US Embassy Marine Corps guard, which regularly kicked our butts every week. After all, they had nothing to do all day but play basketball. But they also gave us access to the Tokyo PX where you could get a bottle of Johnny Walker Red for $3.00, versus the local retail price of $100.00.

I managed to eventually get a job at Dai Nana Securities to teach English to the sales staff there. The first oil shock had just taken place and the sole buyers of shares in the world were all in the Middle East.

After two weeks of trying, I met with the president of the company, Mr. Saito, and told him his staff would never learn English. They just lacked the language gene. But if he taught me the stock business, I would sell the shares for him.

He said OK.

Thus, I ensued on a crash course on securities analysis, relying heavily on the firm’s only copies of the 1934 book, Securities Analysis by Benjamin Graham, and his 1949 tome, The Intelligent Investor. I still have a copy of the first research report I wrote on electric tool maker Makita.

It wasn’t long before I became the top salesman at Dai Nana, eventually selling up to 5% holdings in the top 200 Japanese companies to the Saudi Arabia Monetary Authority, the Kuwait Investment Authority, and the Abu Dhabi Investment Authority.

Then the stock market crashed. I lost my job. So, I started asking around the Press Club if anyone had any work. I was broke and nearly homeless.

At the time, most of the correspondents had just returned from covering the Vietnam War. In Japan, they wanted to cover politics, geisha girls, and Emperor Hirohito. Business was at the very bottom of the list. Besides, no one cared what happened in Japan anyway.

It turned out that all the members of the Press Club basketball team were business journalists. There was Mike Tharpe from the Wall Street Journal, Tracy Dalby from the New York Times, and Richard Hanson from the Associated Press, all NCAA college athletes.

Then one team member, The Economist correspondent, Doug Ramsey, asked me if I could write a story about the Japanese steel industry, which was then aggressively dumping product in the US, killing American jobs and creating a political firestorm. Using my stock market contacts, I spent a week diligently researching the subject.

The editors in London loved the story and said they’d take two a week at $75 each. Then the Financial Times heard about me and said they’d also take two a week. All of a sudden, I had a full-time job paying the princely sum of $1,200 a month!

I eventually built up a global syndicate of 40 business publications in ten countries. By 26, I was earning $100,000 a year and published several books. At my peak I accounted for about half of all business news coming out of Japan, along with stringer jobs with the British Broadcasting Corp. in London and NBC in New York.

This was all from a person whose only “C” in college was in English. Officially, I didn’t know how to write back then.

Officially, I still don’t.

Stay Healthy,
John Thomas
CEO & Publisher
The Diary of a Mad Hedge Fund Trader

 

 

 

 

 

 

 

 

 

https://www.madhedgefundtrader.com/wp-content/uploads/2022/02/foreign-correspondent-ID.png 544 864 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2022-02-14 10:02:272022-02-14 15:49:04The Market Outlook for the Week Ahead, or Welcome to WWIII
Mad Hedge Fund Trader

February 9, 2022

Tech Letter

Mad Hedge Technology Letter
February 9, 2022
Fiat Lux

Featured Trade:

(THE TELEHEALTH TRADE GETS CROWDED)
(TDOC), (AMZN)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2022-02-09 16:04:042022-02-09 16:31:56February 9, 2022
Mad Hedge Fund Trader

The Telehealth Trade Gets Crowded

Tech Letter

The last thing anyone should do with their money now ­— invest in telehealth provider Teladoc (TDOC).

Infringing on Amazon’s (AMZN) moat is equal to a death sentence and TDOC will soon understand how punishing it can be competing with a monopolistic oligarch.

Amazon just announced that Amazon care is now available all over America.

This service offers both virtual care and in-person services.

The Amazon Care model is desperately needed in a country where pharma has gouged the average citizen.

This much-needed health solution from the ecommerce juggernaut is to address shortfalls in current offerings for healthcare and has TDOC squarely in their crosshairs.

The in-person services are rolling out in more than 20 new cities this year and that’s just not the end of it — Amazon says the expansion comes as it continues to invest in growing its clinical care team and its in-person care services.

Remember that TDOC rode the momentum of the hard lockdowns to become one of the few pandemic tech darlings of 2020.

Fast forward to post-2020, TDOCs stock price is down by more than 70% over the past 12 months, and I hope that readers didn’t buy it at the peak!

Obviously, the telehealth company's rising sales serve as a bright spot, but sadly, the company is a one-trick pony like Facebook.

The one-trick ponies of the world are now receiving a discount when they used to receive a premium on their stock price.

The synergies of multi-industry tech firms are evident as shifting resources is way easier to do than hiring from scratch in a tight labor market. 

Granted, TDOCs numbers stand up quite nicely for now, in the third quarter, its revenue grew by 81% year over year to $522 million, and investors are likely to see more big growth when it reports on Q4 in February.

In 2020, its total membership topped 73 million people, for whom it facilitated a total of 10.6 million telehealth visits throughout the year.

However, we don’t operate in a vacuum and one’s competitive advantage can be lost in a blink of an eye.

The reality is that incremental growth will never return to its early pandemic pace when millions of people were seeking ways to get medical assistance without going to doctors' offices.

Teladoc is loss-making and margins are getting worse.

When we add AMZN into the mix, margins will most likely get squeezed more and expenses balloon further which is never a great marriage.

Next, insurmountable challenges could be around the corner and TDOC might be in front store window for a bigger company to purchase.

TODCs management is planning to increase its average annual revenue per subscriber by as much as 25% by offering a wider range of services, potentially including remote monitoring of a patient's medical sensors.

But the question is how much of that proposed 25% will be eaten by AMZN with its brand name and army of talented employees?

In addition, TDOC's costs of providing service are dropping, albeit slowly, but I would argue that AMZN can scale better than anyone in corporate America.

Over the past three years, Teladoc's cost of goods sold has fallen as a percentage of its revenue, and its quarterly gross profits have risen by 320%, but profitability is still years off.

If this becomes a battle between two loss-making telehealth companies that are burning cash, AMZN is really the last company I would want to try my luck out against.

This year will be the year where TDOC either sinks or swims and if it sinks, we will all know why.

Avoid TDOC for now.

 

telehealth

 

telehealth

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2022-02-09 16:02:042022-02-18 16:54:12The Telehealth Trade Gets Crowded
Mad Hedge Fund Trader

February 8, 2022

Diary, Newsletter, Summary

Global Market Comments
February 8, 2022
Fiat Lux

Featured Trades:

(WHY TECHNICAL ANALYSIS NEVER WORKS)
(FB), (AAPL), (AMZN), (GOOG), (MSFT), (VIX)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2022-02-08 10:04:342022-02-08 14:27:03February 8, 2022
Mad Hedge Fund Trader

February 7, 2022

Tech Letter

Mad Hedge Technology Letter
February 7, 2022
Fiat Lux

Featured Trade:

(A MIXED BAG FOR AMAZON)
(FB), (AMZN), (GOOGL)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2022-02-07 13:04:062022-02-07 14:06:27February 7, 2022
Mad Hedge Fund Trader

A Mixed Bag for Amazon

Tech Letter

Ecommerce had to cool off, didn’t it?

After 2 years of breakneck growth, Amazon (AMZN) came crashing back down to life reporting its slowest revenue growth in 4 years.

Amazon’s online stores reported $206 million in losses for the U.S. revealing that American online shopping has plateaued for the short-term.

Much of this was baked into the equation as Amazon shares have really done nothing for the past 6 months.

The sugar high it received from the pandemic is starting to wear off.

AMZN experienced more than $4 billion in costs from inflationary pressures, lost productivity, and disruptions. The inflation primarily relates to wage increases and incentives in the operations, as well as higher pricing from third-party carriers supporting AMZNs fulfillment network. Lost productivity and network disruptions were driven primarily by labor capacity constraints due to challenges in staffing up AMZN facilities.

Then when the omicron variant reared its ugly head, there was a certain conflict with retaining staff as many workers called out sick, making an already tight labor force less efficient.

If the earnings report stopped just there, no doubt AMZN would have braced for a Facebook-like 25% selloff, but the silver linings in the AMZN report were more like a gold lining.

Three positive data points that couldn’t be downplayed were in the Amazon Web Services (AWS) business, the advertising business, and pricing for Amazon Prime membership.

AWS delivered a strong quarter of growth, as enterprises and developers continued to look to AWS for critical, innovative cloud solutions.

A vivid example of AWS is with Amazon’s relationship with parent company of Chrysler, Dodge, Fiat, Jeep, and Ram.

They selected AWS as its preferred global cloud provider for vehicle platforms to accelerate new digital products and upskill its global workforce.

There’s a whole list of the world's largest companies that now use AWS like Adidas, Goldman Sachs, Pfizer, Rivian.

AWS revenue expanded to 40% from a year ago to $17.8 billion, and represents the anchor for the financial health of Amazon.

It allows AMZN to pursue other growth levers like advertising.

What happens is that there is an intense feedback loop with customers, to keep building and making that better.

The end result is building more relevancy and better engaging experiences.

Interaction promotes an understanding that AMZN can build better analytic tools, provide better measurement, give them better insight to performance.

Amazon’s focus on serving brands has really differentiated themselves from the likes of Facebook (FB) and Google (GOOGL).

The sponsored ad space with regards to video advertising is certainly a great opportunity.

And again, this is about delivering good recommendations to customers and helpful when they're making their purchase decisions and giving them information around that.

In the end, advertising grew 32% year over year and is a $10 billion business.

The most aggressive move that Amazon told us about is their price rise for Prime Membership.

Amazon will increase the price of a Prime membership in the United States, with the monthly price going from $12.99 to $14.99 and the annual membership going from $119 to $139.

The 15% increase is the first price increase since 2018 which should be a boon to the bottom line.

Ultimately, I believe the Amazon Prime Membership price hike was the reason for the investor response of bidding up AMZN shares.

Although the ecommerce numbers were a little disappointing, they should rebound nicely in 2022.

The bar was set extremely low coming into the earnings and AMZN gave us enough juice for shares to surge.

When combining the positives of AWS and advertising strength, this ecommerce behemoth’s momentum is just too hard to ignore.

If inflation starts to moderate, expect AMZN’s stock to be 25% higher by the end of the year and I do believe investors will sell out of Facebook and buy into a quality stock like AMZN.

amzn

 

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2022-02-07 13:04:022022-02-16 02:47:28A Mixed Bag for Amazon
Mad Hedge Fund Trader

February 4, 2022

Tech Letter

Mad Hedge Technology Letter
February 4, 2022
Fiat Lux

Featured Trade:

(FACEBOOK IS BROKEN)
(FB), (AMZN), (MSFT), (AAPL)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2022-02-04 15:04:582022-02-04 16:06:20February 4, 2022
Mad Hedge Fund Trader

Facebook is Broken

Tech Letter

Facebook (FB) is broken.

As a stock, management team, product, and as a business model – it is broken.

This portends poorly for the company that Mark Zuckerberg built.

Funnily enough, Zuckerberg decided to opt for a new company name, "Meta," to signal to his investors that the company is barreling straight into a new chapter of its existence.

The problem I have with Meta is that they face 10 years of losses before they can potentially spin a profit from a Metaverse-based product.

Reading the tea leaves, the name change appears to mask the internal destruction of the legacy Facebook model, and the warning signs are more than a few.

They are in the digital ad business at a time when e-commerce company Amazon (AMZN) is rapidly encroaching on their turf.

I would argue that it was Facebook who completely missed out on e-commerce, almost like how Microsoft (MSFT) missed out on the cell phone business that Apple were able to figure out.

The final kick below the belt was Facebook admitting that Apple’s (AAPL) privacy changes have materially affected Facebook’s ability to collect large swaths of data.

The result is less accurate and voluminous data because they can’t steal as much reducing the amount they can charge digital advertisers for the data.

Facebook’s underperformance is the most complete anecdotal evidence so far on the impact to the advertising industry of Apple’s App Tracking Transparency feature, which minimizes targeting capabilities by limiting advertisers from accessing an iPhone user identifier.

Even with the terrible report, I don’t believe a 26% haircut in Meta shares was warranted, but this represents the sign of the times where companies aren’t given a free pass anymore.

If something like this were to happen in a period of easy money, I believe Meta would have only sold off 4%-6%.

So how about that Metaverse business?

Chief Executive Officer Mark Zuckerberg announced Wednesday that Meta had a net loss of $10 billion in 2021 attributable to its investment in the Meeetaverse.

I believe this is a risky stance to take considering it’s not fully guaranteed that the Metaverse will be what all the experts think it might turn into.

It could still only pull through in a diluted way like many things in life.

Amazon has really broken away from the pack, from an advertising minnow into an ad revenue juggernaut with annual sales of $31 billion for 2021, which is more than the $28.8 billion in ad revenue that YouTube posted for the year.

At that pace, Amazon’s ad business is also larger than several other entities in online advertising, including cloud rival Microsoft, whose CEO, Satya Nadella, disclosed last week the company’s 2021 advertising revenue exceeded $10 billion.

Amazon has also decided to increase the price of Prime by nearly 17% all while Facebook lacks pricing power to charge digital ad manufacturers more.

It’s time to retire the acronym starting with F – FANG, which once represented the equity market profile of Facebook, Apple, Netflix, and Google.

Is this the end of Facebook?

No, they still have a sterling balance sheet and are awfully profitable in what they do.

But looking forward, growth rates will contract down to single digits and user growth has turned negative.

These are both ominous signs with no solutions in sight.

Have we seen the high-water mark for Facebook?

Fixing its stock trajectory to the backs of the metaverse is a fool’s game because of the large losses it will incur in the short to mid-term.

Zuckerberg largely understands the Metaverse as an existential crisis of epic proportions, which is why he’s throwing the kitchen sink at it.

Broadly speaking, the stock market might have a Facebook problem because the company is so valuable and part of so many indices that a dip in shares will hurt the wider market.

In any case, the bombshell report means that this bodes poorly for the 3-year trajectory of Meta’s stock; and to give Meta the benefit of the doubt, at least they have the cash to make a legitimate run at the Metaverse business.

Don’t expect high octane price action in Meta until they signal that the Metaverse business is legitimate and just around the corner, which might be a while!

My recommendation is to put this one on the backburner until prospects brighten up.

 

meta

 

 

meta

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2022-02-04 15:02:462022-02-15 23:31:47Facebook is Broken
Mad Hedge Fund Trader

February 3, 2022

Biotech Letter

Mad Hedge Biotech and Healthcare Letter
February 3, 2022
Fiat Lux

Featured Trade:

(A ‘BORING’ BUSINESS RESISTING THE ‘AMAZON EFFECT’)
(CVS), (UNH), (ANTM), (TDOC), (AMZN), (BRK.A), (BRK.B), (JPM)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2022-02-03 19:02:052022-02-03 19:17:25February 3, 2022
Mad Hedge Fund Trader

A 'Boring' Business Resisting the 'Amazon Effect'

Biotech Letter

The healthcare market is under attack.

Amazon (AMZN) is invading the healthcare sector, wielding its far-reaching online presence and countless distribution warehouses to dominate the market.

Leveraging its ability to offer quick shipping to practically all locations, Amazon has transformed into a grab-anything-and-everything-possible business.

Now, it has set its sights on the healthcare and prescription sector. In fact, it has been attempting to infiltrate this segment since 2018 when it acquired PillPack.

The only limitation of that deal was that customers still had to get prescriptions from their doctors to avail of the PillPack service.

However, Amazon’s not the only one seeing the potential of this sector.

Following the difficulties it encountered in cornering the market, the e-commerce giant collaborated with fellow Wall Street titans Berkshire Hathaway (BRK.A) (BRK.B) and JPMorgan (JPM). Together, the three companies launched a service they called “Haven.”

Unfortunately, the venture eventually fell apart, and they canceled the deal altogether.

Despite that unfortunate end, Amazon refuses to back down on its vision. Recently, it decided to take another stab at the venture with a rebranding, giving birth to AmazonCare.

The goal is to offer assistance to customers in booking doctor appointments and receiving prescriptions online.

Undeniably, any business endeavor with Amazon’s backing will make waves in any industry. Nonetheless, this new venture could still be a tough sell.

For now, the company's strength is hoping to use the “Amazon effect” to sway members into signing up and using AmazonCare as well.

Surprisingly, Amazon finds itself facing an unlikely challenger in this pursuit: CVS (CVS).

Like Amazon, Berkshire, and JPMorgan, CVS has also recognized the potential of this market.

Unlike Amazon’s partners, CVS has decided to invest to become a frontrunner in terms of dominating the same sector and eventually taking advantage of this rapidly expanding total addressable market.

Instead of following the track of its fellow healthcare providers, such as UnitedHealth (UNH) and Anthem (ANTM), CVS has opted to change its angle of attack in the hopes of gaining more market share and reaping higher profits.

CVS is putting to good use its over 9,900 stores and distributions as means to establish better connections and rapport with customers.

After all, statistics indicate that approximately 80% of American citizens live less than 10 miles from a CVS branch.

This offers CVS a competitive advantage in terms of proximity to its customers. That is, it offers a unique convenience as it serves as the ever-present “corner stores” in practically every city.

Leveraging the locations, CVS has set up about 1,500 branches into “HealthHubs” by the end of 2021.

Basically, HealthHubs serve as emergency care clinics found inside CVS stores, providing customers with easy access to convenient and even cheaper after-hours health checkups.

Aside from this feature, a growing number of CVS stores are starting to get set up to be able to ship medicines or any other products ordered online, while other branches are being eyed as potential UPS drop-off points.

This setup will transform several branches into convenient “mini” distribution centers.

CVS has broken out of its “boring corner drugstore” image following its decision to target a more lucrative and massive healthcare sector.

It started the ball rolling when it acquired Aetna for $69 billion—a decision that so many investors disapproved of at that time.

Until recently, the market has largely ignored CVS because of the debt it incurred from the Aetna deal.

However, the tides had turned when investors finally realized that the drugstore giant had been efficiently and effectively executing a brilliant strategy all this time.

With Aetna under its wing, CVS has been granted access to a multitude of healthcare and managed care benefits availed by more than 23 million members. The sheer number of subscribers transformed the company into the third-biggest health insurer in the United States—next only to decades-long established providers Anthem and UnitedHealth.

Riding this momentum, CVS has been aggressive in revamping its image and expanding its services.

On top of its HealthHubs and Aetna advantages, CVS has recently paired up with Teladoc (TDOC) to leverage its virtual healthcare services to offer even more convenience to its customers.

This is another massive market since CVS already has roughly 35 million digital customers subscribed to its CVS app.

These users are all ordering products and other prescriptions from CVS. Integrating Teladoc’s services to the mix would be a surefire way of boosting its membership and adding a lucrative revenue stream.

Keep in mind that the global market for telehealth services is projected to expand somewhere between $300 billion to $700 billion by 2028—and that’s a conservative estimate.

CVS’ move to use Teladoc software is a positive indication of early technology adoption, positioning the drugstore chain at the forefront of a healthcare revolution.

Overall, CVS can only be described as a company striving to become a unique business that offers a range of products that no one else in the industry provides.

Although it’s improbable that it’ll sustain a monopoly in these services, CVS has been gradually transforming and growing into an almost unbeatable force in the industry by leveraging its strengths in an effective and logical method.

Moreover, it has evolved from a stodgy drugstore into an early tech adopter and a revolutionary business that can stand to challenge the likes of Amazon.

 

cvs healthcare

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2022-02-03 19:00:022022-02-15 22:41:17A 'Boring' Business Resisting the 'Amazon Effect'
Page 28 of 101«‹2627282930›»

tastytrade, Inc. (“tastytrade”) has entered into a Marketing Agreement with Mad Hedge Fund Trader (“Marketing Agent”) whereby tastytrade pays compensation to Marketing Agent to recommend tastytrade’s brokerage services. The existence of this Marketing Agreement should not be deemed as an endorsement or recommendation of Marketing Agent by tastytrade and/or any of its affiliated companies. Neither tastytrade nor any of its affiliated companies is responsible for the privacy practices of Marketing Agent or this website. tastytrade does not warrant the accuracy or content of the products or services offered by Marketing Agent or this website. Marketing Agent is independent and is not an affiliate of tastytrade. 

Legal Disclaimer

There is a very high degree of risk involved in trading. Past results are not indicative of future returns. MadHedgeFundTrader.com and all individuals affiliated with this site assume no responsibilities for your trading and investment results. The indicators, strategies, columns, articles and all other features are for educational purposes only and should not be construed as investment advice. Information for futures trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Affiliates of MadHedgeFundTrader.com may have a position or effect transactions in the securities described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies.

Copyright © 2025. Mad Hedge Fund Trader. All Rights Reserved. support@madhedgefundtrader.com
  • Privacy Policy
  • Disclaimer
  • FAQ
Scroll to top